双镜联合治疗胆囊结石合并肝外胆管结石患者疗效及安全性分析*

doi:10.3969/j.issn.1672-5069.2023.06.038

摘要/Abstract

摘要： 目的探讨采取双镜联合治疗胆囊结石(GS)合并肝外胆管结石(EBDS)患者的疗效及安全性。方法 2020年1月～2022年12月我院收治的GS合并EBDS患者76例,其中观察组42例接受内镜下逆行胰胆管造影术(ERCP)治疗,5 d后进行腹腔镜下胆囊切除术(LC)治疗,对照组34例接受传统开腹手术治疗。采用视觉模拟评分法(VAS)评估疼痛程度,采用ELISA法检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、C反应蛋白(CRP)和皮质醇(Cor)。结果两组结石清除率均为100.0%,观察组手术时间、术中出血量和术后3 d VAS评分分别为(96.8±7.4)min、(25.7±5.3)ml和(2.8±0.7)分,显著短于或少于对照组【分别为(120.1±9.6)min、(46.0±6.8)ml和(3.5±0.6)分,P＜0.05】; 在术后7 d,观察组血清AST和ALT水平分别为(40.5±3.9)U/L和(43.1±4.9)U/L,显著低于对照组【分别为(50.2±5.0)U/L和(56.9±6.0)U/L,P＜0.05】;观察组血清TNF-α、IL-6、CRP、Cor和外周血WBC计数分别为(1.5±0.3)ng/L、(10.8±2.0)ng/L、(13.4±2.5)mg/L、(224.7±28.1)mmol/L和(9.8±1.3)×10⁹/L,均显著低于对照组【分别为(2.7±0.5)ng/L、(16.1±2.5)ng/L、(22.0±4.9)mg/L、(262.4±31.8)mmol/L和(12.0±1.5)×10⁹/L,P＜0.05】;术后,观察组并发症发生率为7.2%,显著低于对照组的23.5%(P＜0.05)。结论采用双镜联合治疗GS合并EBDS患者能有效改善围术期指标,促进术后恢复,缓解应激反应,减少并发症。

关键词: 胆囊结石, 肝外胆管结石, 内镜下逆行胰胆管造影术, 腹腔镜胆囊切除术, 治疗

Abstract: Objective This study was conducted to investigate double endoscopic surgery in the treatment of patients with gallbladder stones (GS) and extrahepatic bile duct stones (EBDS). Methods 76 patients with GS and EBDS were encountered in our hospital between January 2020 and December 2022, 42 patients in the observation group received laparoscopic cholecystectomy (LC) five days after endoscopic retrograde cholangiopancreatography (ERCP) for the removal of common bile duct stones, and 34 patients in the control underwent traditional open surgery. The pain was evaluated by visual analogue scale (VAS), and serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP) and cortisol (Cor) levels were detected by ELISA. The white blood cell counts (WBC) were detected by full-automatic blood cell analyzer. Results The stone clearance rates in the two groups were both 100.0%; the operation time, intraoperative blood loss and VAS score at day 3 after surgery in the observation were(96.8±7.4)min,(25.7±5.3)ml and (2.8±0.7), significantly shorter or less than [(120.1±9.6)min, (46.0±6.8)ml and (3.5±0.6), respectively, P＜0.05] in the control; seven days after operation, serum AST and ALT levels were (40.5±3.9)U/L and (43.1±4.9)U/L, both significantly lower than [(50.2±5.0)U/L and (56.9±6.0)U/L, P＜0.05] in the control; serum TNF-α, IL-6, CRP, Cor levels and WBC counts were (1.5±0.3)ng/L, (10.8±2.0)ng/L, (13.4±2.5)mg/L, (224.7±28.1)mmol/L and (9.8±1.3)×10⁹/L, all significantly lower than [(2.7±0.5)ng/L, (16.1±2.5)ng/L, (22.0±4.9)mg/L, (262.4±31.8)mmol/L and (12.0±1.5)×10⁹/L, respectively, P＜0.05] in the control; post-operationally, the incidence of complications in the observation group was 7.2%, much lower than 23.5%(P＜0.05) in the control. Conclusion The double endoscopic surgery could effectively improve perioperative indexes, promote postoperative recovery, relieve stress response and reduce the complications in patients with GS and EBDS.

Key words: Gallstone stone, Extrahepatic bile duct stone, Endoscopic retrograde cholangiopancreatography, Laparoscopic cholecystectomy, Treatment

古乾权, 陈杰, 邓开. 双镜联合治疗胆囊结石合并肝外胆管结石患者疗效及安全性分析^*[J]. 实用肝脏病杂志, 2023, 26(6): 919-922.

Gu Qianquan, Chen Jie, Deng Kai. Double endoscopic surgery in the treatment of patients with gallbladder stones and extrahepatic bile duct stones[J]. Journal of Practical Hepatology, 2023, 26(6): 919-922.

参考文献

[1] 张振胜, 陈升, 肖洪伟, 等. 双镜联合保胆取石术与腹腔镜胆囊切除术治疗胆囊结石患者疗效对比分析. 实用肝脏病杂志, 2022, 25(1):132-135.
[2] Wiegering A, Müller S, Petritsch B, et al. Temporal sequence of bile duct clearance with simultaneous cholecystolithiasis or choledocholithiasis-preoperative, intraoperative or postoperative? Chirurgie (Heidelb), 2022, 93(6):542-547.
[3] Medhioub M, Khsiba A, Mahmoudi M, et al. Preoperative endoscopic treatment for the management of concomitant gallstones and common bile duct stones. Tunis Med, 2021, 99(2):233-237.
[4] Yeh CN, Wang SY, Liu KH, et al. Surgical outcome of Mirizzi syndrome: value of endoscopic retrograde cholangiopancreatography and laparoscopic procedures. J Hepatobiliary Pancreat Sci, 2021, 28(9):760-769.
[5] Qu JW, Xin C, Wang GY, et al. Feasibility and safety of single-incision laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy in an ambulatory setting. Hepatobiliary Pancreat Dis Int, 2019, 18(3):273-277.
[6] Kourounis G, Gall LS, McArthur D, et al. Choledocholithiasis: Long-term follow-up in patients without stone clearance at first endoscopic retrograde cholangiopancreatography. J Dig Dis, 2021, 22(9):551-556.
[7] Zhu J, Zhang Y, Du P, et al. Systematic review and meta-analysis of laparoscopic common bile duct exploration in patients with previous failed endoscopic retrograde cholangiopancreatography. Surg Laparosc Endosc Percutan Tech, 2021, 31(5):654-662.
[8] 杨甲梅. 实用肝胆外科学. 上海:上海人民出版社, 2009:15-16.
[9] Umemura A, Suto T, Nakamura S, et al. Comparison ofsingle-incision laparoscopic cholecystectomy versus needlescopic cholecystectomy: a single institutional randomized clinical trial. Dig Surg, 2019, 36(1):53-58.
[10] Guo T, Wang L, Xie P, et al. Surgical methods of treatment for cholecystolithiasis combined with choledocholithiasis: six years' experience of a single institution. Surg Endosc, 2022, 36(7):4903-4911.
[11] Latenstein CSS, de Jong JJ, Eppink JJ, et al. Prevalence of dyspepsia in patients with cholecystolithiasis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol, 2019, 31(8):928-934.
[12] Payá-Llorente C, Domingo-Del Pozo C, Gonzálvez-Guardiola P, et al. Conversion to open surgery during laparoscopic common bile duct exploration: predictive factors and impact on the perioperative outcomes. HPB (Oxford), 2022, 24(1):87-93.
[13] Saito H, Imamura H, Matsushita I, et al. Immediate or interval endoscopic papillary large-balloon dilation after limited endoscopic sphincterotomy for bile duct Stone Removal. Intern Med, 2021, 60(17):2713-2718.
[14] Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: endoscopic and surgical approaches. World J Gastroenterol, 2021, 27(28):4536-4554.
[15] Liu H, Pan W, Yan G, et al. A retrospective cohort study on the optimal interval between endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy. Medicine (Baltimore), 2022, 101(27):e29728.
[16] Mukai S, Itoi T, Tsuchiya T, et al. Urgent and emergency endoscopic retrograde cholangiopancreatography for gallstone-induced acute cholangitis and pancreatitis. Dig Endosc, 2023, 35(1):47-57.
[17] Schepers NJ, Hallensleben NDL, Besselink MG, et al. Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial. Lancet, 2020, 396(10245):167-176.
[18] 刘小飞, 张大伟, 罗宏宇, 等. 腹腔镜胆囊切除术联合内镜下逆行胰胆管造影和十二指肠乳头括约肌切开术治疗胆囊结石合并肝外胆管结石患者疗效研究. 实用肝脏病杂志, 2021, 24(5):753-756.
[19] 张立洪, 陶立德, 曾佳, 等. 保护Oddi括约肌功能的三镜联合治疗胆总管结石合并胆囊结石. 中华普通外科杂志, 2019, 34(11):994-995.
[20] Lyu Y, Cheng Y, Li T, et al. Laparoscopic common bile duct exploration plus cholecystectomy versus endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for cholecystocholedocholithiasis: a meta-analysis. Surg Endosc, 2019, 33(10):3275-3286.
[21] Zou Q, Ding Y, Li CS, et al. A randomized controlled trial of emergencyLCBDE +LC and ERCP + LC in the treatment of choledocholithiasis with acute cholangitis. Wideochir Inne Tech Maloinwazyjne, 2022, 17(1):156-162.
[22] Lei C, Lu T, Yang W, et al. Comparison of intraoperative endoscopic retrograde cholangiopancreatography and laparoscopic common bile duct exploration combined with laparoscopic cholecystectomy for treating gallstones and common bile duct stones: a systematic review and meta-analysis. Surg Endosc, 2021, 35(11):5918-5935.
[23] Ng HJ, Nassar AHM. Reinterventions following laparoscopic cholecystectomy and bile duct exploration. a review of prospective data from 5740 patients. Surg Endosc, 2022, 36(5):2809-2817.

双镜联合治疗胆囊结石合并肝外胆管结石患者疗效及安全性分析^*

Double endoscopic surgery in the treatment of patients with gallbladder stones and extrahepatic bile duct stones

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨蕊旭, 齐明华. 慢性HBV感染合并代谢相关性脂肪性肝病患者抗病毒治疗对策^*[J]. 实用肝脏病杂志, 2023, 26(6): 773-776.
[2]	宋涛, 徐敏, 党子龙, 孙珺珺. 恩替卡韦联合α-干扰素治疗慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 785-788.
[3]	高丽娟, 李永库, 董新颖, 杨艺宁, 冷雪君. 艾米替诺福韦治疗慢性乙型肝炎患者疗效初步研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 789-792.
[4]	周季颖, 谢月红, 于翠霞. 恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪性肝病患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 793-796.
[5]	曹汴川, 刘梅, 丁苹, 汤玲毓, 郭明贤, 周仙, 袁天茹, 严一凯, 黄富礼, 黄永茂. 格卡瑞韦/哌仑他韦治疗HCV感染者和人类免疫缺陷病毒合并HCV感染者疗效及安全性研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 801-804.
[6]	王卓雅, 吴洋鹏, 黄益桃. 还原型谷胱甘肽联合护肝清脂片治疗非酒精性脂肪性肝病患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 823-826.
[7]	陈雅君, 朱婧, 李璐, 何钦. 标准免疫抑制疗法联合异甘草酸镁治疗自身免疫性肝炎患者外周血B细胞和调节性B细胞变化^*[J]. 实用肝脏病杂志, 2023, 26(6): 835-838.
[8]	杨开宁, 王梦梦, 王占坤, 陈秀秀, 肖剑, 王永丽. 注射用谷胱甘肽联合硫普罗宁治疗药物性肝损伤患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 839-842.
[9]	王新月, 周莉, 董金玲, 陈煜. 双重血浆分子吸附系统治疗肝衰竭患者应用甲磺酸萘莫司他与肝素抗凝有效性与安全性比较研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 843-846.
[10]	姜亚超, 尹力, 颜状. “改良三明治夹心法”行ESVD术治疗肝硬化并发食管胃静脉曲张患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 863-866.
[11]	刘公攀, 陈涛, 丁志刚, 任明, 郭兴军, 邵存华, 卢建树. CalliSpheres可载药微球经导管肝动脉化疗栓塞序贯射频消融治疗原发性肝癌患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 879-882.
[12]	于双杰, 李元元, 毕京峰, 福军亮, 宓余强. ICIs联合TKIs治疗HBV相关肝细胞癌患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 891-894.
[13]	刘思宏, 谢琉嘉, 周志明, 许亚春. CEUS联合MRI增强扫描早期评价射频消融治疗原发性肝癌患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 895-898.
[14]	青秀, 周沙, 刘斌. HIFU消融联合化疗治疗中晚期肝母细胞瘤小儿5年随访研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 911-914.
[15]	刘明, 王金婷, 杨士彦, 杨位轩, 万元春. ESPBD与EST治疗肝硬化合并胆总管结石患者疗效比较^*[J]. 实用肝脏病杂志, 2023, 26(6): 915-918.